| __timestamp | Eli Lilly and Company | Viridian Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 4733600000 | 293000 |
| Thursday, January 1, 2015 | 4796400000 | 1002000 |
| Friday, January 1, 2016 | 5243900000 | 888000 |
| Sunday, January 1, 2017 | 5281800000 | 19623000 |
| Monday, January 1, 2018 | 5051200000 | 30421000 |
| Tuesday, January 1, 2019 | 5595000000 | 34794000 |
| Wednesday, January 1, 2020 | 6085700000 | 28304000 |
| Friday, January 1, 2021 | 7025900000 | 56886000 |
| Saturday, January 1, 2022 | 7190800000 | 100894000 |
| Sunday, January 1, 2023 | 9313400000 | 159765000 |
| Monday, January 1, 2024 | 14271000000 |
Data in motion
In the competitive landscape of pharmaceuticals, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Eli Lilly and Company has consistently demonstrated its strategic focus on R&D, with expenditures growing by nearly 97% from 2014 to 2023. In contrast, Viridian Therapeutics, Inc., a smaller player, has shown a remarkable increase in R&D spending, skyrocketing by over 54,000% during the same period, albeit from a much smaller base.
Eli Lilly's robust investment, peaking at approximately $9.3 billion in 2023, underscores its dedication to maintaining a competitive edge in the pharmaceutical industry. Meanwhile, Viridian's aggressive R&D growth, reaching around $160 million in 2023, highlights its ambition to innovate and expand its market presence. This juxtaposition of R&D strategies offers a fascinating glimpse into the diverse approaches companies take to drive growth and innovation.
R&D Spending Showdown: Eli Lilly and Company vs Dr. Reddy's Laboratories Limited
Who Prioritizes Innovation? R&D Spending Compared for Eli Lilly and Company and Madrigal Pharmaceuticals, Inc.
Comparing Innovation Spending: Eli Lilly and Company and Opthea Limited
Comparing Innovation Spending: Eli Lilly and Company and Ionis Pharmaceuticals, Inc.
Eli Lilly and Company vs Veracyte, Inc.: Strategic Focus on R&D Spending
Eli Lilly and Company or Ligand Pharmaceuticals Incorporated: Who Invests More in Innovation?
Novartis AG vs Viridian Therapeutics, Inc.: Strategic Focus on R&D Spending
Bio-Techne Corporation or Viridian Therapeutics, Inc.: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for Corcept Therapeutics Incorporated and Viridian Therapeutics, Inc.
Research and Development Investment: Amicus Therapeutics, Inc. vs Viridian Therapeutics, Inc.
Comparing Innovation Spending: Geron Corporation and Viridian Therapeutics, Inc.
Comparing Innovation Spending: Celldex Therapeutics, Inc. and Viridian Therapeutics, Inc.